Navigation Links
Manipulating the Brain to Eliminate Fear or Restore Memories – Rudy Mazzocchi Releases the 2nd Novel in The EQUITY Series entitled "EQUITY of FEAR"
Date:4/2/2013

New York, NY (PRWEB) April 02, 2013

The first book in The EQUITY Series, EQUITY of EVIL, quickly catapulted to the top of the charts on Amazon as the #1 Medical Thriller based on Average Customer Reviews. Three literary awards, including the 2012 Global eBook Award for Best Suspense Thriller, further enhanced the brand recognition of this debut novel. With growing momentum in a competitive industry, Mazzocchi is quickly following with the release of his second novel that seems to promise the same suspense, intensity and international intrigue.

EQUITY of FEAR, published by Twilight Times Books (Kingsport, TN), was released on March 25, 2013 in eBook format and will be available as a print edition in July. As with the first thriller in this series, EQUITY of EVIL, Mazzocchi once again pulls from personal business experiences to build a story of suspense – this time based on the medical science of neuroplasticity, the rewiring of the brain.

Synopsis of EQUITY of FEAR:

Researchers and scientists in the U.S., Russia and Japan compete in a new technological race to control fear and pain in the minds of the world’s populace. At first, the race is rooted in purely scientific ambitions, such as that of space travel or in the era of industrial revolution, but it evolves into something much more sinister.

What might governments or powerful organizations do or pay for the keys to control the fear of pain or the fear of death? What limits would prevent them from eliminating anything or anyone standing in the way? How far would they go to control the monopoly over a technology that could subliminally control the human brain, and what power would they have over the lives of billions, if successful?

Here is yet another dark world where scientists experiment on orphaned children rather than rhesus monkeys, where torture and pain become just another set of data points and lives are discarded for the sake of owning the ability to control how man perceives and processes fear.

Book Trailer: http://bit.ly/11nFRHv

About Mazzocchi:

Rudy is best known as a medical device and biotechnology entrepreneur, inventor, and angel investor, with a history of starting new technology ventures throughout the U.S. and Europe. He’s been privileged to have the opportunity to see the newest innovations in healthcare and work with some of the most brilliant researchers, scientists and physicians in the industry.

Authoring more than 50 patents, he has helped pioneer new companies involved in cardiology, oncology, orthopedics, neurosurgery and even embryonic stem-cell development. Through these efforts, he has become the recipient of many technology and business awards, including the Ernst & Young Entrepreneur of the Year Award in Healthcare and the National Businessman of the Year Award.

Combining these experiences and opportunities, with thousands of hours of travel and long evenings in hotel rooms, he found the initiative to start writing a collection of medical thrillers based on true events, now referred to as The EQUITY Series.

Read the full story at http://www.prweb.com/releases/Thriller/Mazzocchi/prweb10545132.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Retina transplantation improved by manipulating recipient retinal microenvironment
2. Relay race with single atoms: New ways of manipulating matter
3. Manipulating way bacteria talk could have practical applications, Texas A&M profs say
4. Brain Cancer Researcher Eric Holland, One Of The Worlds Top Neurosurgeons, To Join Fred Hutch And UW Medicine
5. National Brain Tumor Society Announces Launch of Defeat GBM Research Collaborative
6. Transplanted brain cells in monkeys light up personalized therapy
7. NSBRI Funds Cerebrotech to Accelerate Development of Brain Monitoring Device
8. Study: Brain Imaging After Mild Head Injury/Concussion Can Show Lesions
9. Enhanced brain acetate metabolism may reward heavy drinkers
10. Ectopic eyes function without connection to brain
11. Blueprint for an artificial brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , December 8, 2016 ... für Molekulargenetik, erweitert seine Palette an anpassbaren SureSeq™ ... Custom FH Panels, das ein schnelles und kostengünstiges ... Das Panel bietet eine Erkennung von Einzel-Nukleotid-Variationen (Single ... mit einem einzigen kleinen Panel und ermöglicht eine ...
(Date:12/8/2016)... ... 08, 2016 , ... Microbial genomics leader, uBiome, joins Google, ... of just six company finalists in the Health & Medicine category. Over 1,000 ... as finalists in this year’s awards include Google, SpaceX, Oculus, and SolarCity. Individuals ...
(Date:12/8/2016)... N.J. , Dec. 8, 2016 ... augmentation remediation technologies and selected NewTechBio,s NT-MAX ... a microbial based beneficial bacteria, in conjunction with ... to correct deficiencies with National Pollutant Discharge Elimination ... 281-8H has experienced a steady history of elevated ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... that “in the setting of previously treated, advanced pancreatic cancer, liquid biopsies are ... optimal patient population and timing of blood sampling may improve the value of ...
Breaking Biology Technology:
(Date:12/8/2016)... ALAMEDA, Calif. , Dec. 8, 2016  Singulex, ... Single Molecule Counting technology, entered into a license and ... in serving science. The agreement provides Singulex access to ... Europe is used to diagnose ... the United States to aid in assessing ...
(Date:12/7/2016)... Israel , December 7, 2016 BioCatch ... the expansion of its patent portfolio, which grew to over 40 granted ... , , ... its recently filed patent entitled " System, Device, and Method ... technology that enables device makers to forego costly hardware components needed to ...
(Date:12/7/2016)... --  Veridium , a leader in biometrics-based authentication ... James Stickland . Stickland, a seasoned financial ... served in senior executive roles for HSBC, JPMorgan ... a pipeline of venture capital and accelerating innovation ... as managing director of U.K.-based fintech firm Red ...
Breaking Biology News(10 mins):